Human Repeat Insult Patch Test to Evaluate Personal Lubricants
NCT ID: NCT02737631
Last Updated: 2021-04-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
222 participants
INTERVENTIONAL
2016-02-29
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Single-Center, Clinical Study to Evaluate the Safety of a New Personal Lubricant in Healthy Female Subjects
NCT02737852
Repeated Insult Patch Test of Personal Lubricants
NCT02297841
14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin
NCT02309294
A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects
NCT02737592
A Single-Center, Clinical Study to Evaluate the Safety of a Fragranced Personal Lubricant in Healthy Female Subjects
NCT02320214
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy subject
Healthy subjects exposed to "Chameleon" personal lubricant via occlusive patch
"Chameleon" Personal Lubricant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"Chameleon" Personal Lubricant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* signed and dated informed consent
* signed and dated HIPAA Form
Exclusion Criteria
* known allergy or sensitivity to cosmetics and toiletries, including sunscreens, adhesives and/or topical drugs
* pre-existing dermatologic conditions which have been diagnosed by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study
* pre-existing other medical conditions (e.g. adult asthma, diabetes).
* treatment with antibiotics, antihistamines or corticosteroids within two weeks prior to initiation of the test
* chronic medication which could affect the results of the study (e.g., insulin, corticosteroids, antihistimines, steroidal or non-steroidal anti-inflammatory drugs \[except for therapeutic maintenance dosage of aspirin\], antibiotics, steroid inhalers, etc.)
* known pregnant or nursing women
18 Years
69 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Church & Dwight Company, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lynne B Harrison, PhD
Role: PRINCIPAL_INVESTIGATOR
Harrison Research Laboratories, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harrison Research Laboratories, Inc.
Union, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ST-7619
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.